Literature DB >> 12798567

Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation.

Craig A Thompson1, Boris A Nasseri, Joshua Makower, Stuart Houser, Michael McGarry, Theodore Lamson, Irina Pomerantseva, John Y Chang, Herman K Gold, Joseph P Vacanti, Stephen N Oesterle.   

Abstract

OBJECTIVES: The study evaluated a nonsurgical means of intramyocardial cell introduction using the coronary venous system for direct myocardial access and cell delivery.
BACKGROUND: Direct myocardial cell repopulation has been proposed as a potential method to treat heart failure.
METHODS: We harvested bone marrow from Yorkshire swine (n = 6; 50 to 60 kg), selected culture-flask adherent cells, labeled them with the gene for green fluorescence protein, expanded them in culture, and resuspended them in a collagen hydrogel. Working through the coronary sinus, a specialized catheter system was easily delivered to the anterior interventricular coronary vein. The composite catheter system (TransAccess) incorporates a phased-array ultrasound tip for guidance and a sheathed, extendable nitinol needle for transvascular myocardial access. A microinfusion (IntraLume) catheter was advanced through the needle, deep into remote myocardium, and the autologous cell-hydrogel suspension was injected into normal heart. Animals were sacrificed at days 0 (n = 2), 14 (n = 1, + 1 control/collagen biogel only), and 28 (n = 2), and the hearts were excised and examined.
RESULTS: We gained widespread intramyocardial access to the anterior, lateral, septal, apical, and inferior walls from the anterior interventicular coronary vein. No death, cardiac tamponade, ventricular arrhythmia, or other procedural complications occurred. Gross inspection demonstrated no evidence of myocardial perforation, and biogel/black tissue dye was well localized to sites corresponding to fluoroscopic landmarks for delivery. Histologic analysis demonstrated needle and microcatheter tracts and accurate cell-biogel delivery.
CONCLUSIONS: Percutaneous intramyocardial access is safe and feasible by a transvenous approach through the coronary venous system. The swine offers an opportunity to refine approaches used for cellular cardiomyoplasty.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12798567     DOI: 10.1016/s0735-1097(03)00397-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  38 in total

Review 1.  Cell delivery routes for stem cell therapy to the heart: current and future approaches.

Authors:  Niall G Campbell; Ken Suzuki
Journal:  J Cardiovasc Transl Res       Date:  2012-05-31       Impact factor: 4.132

Review 2.  Delivery of gene and cellular therapies for heart disease.

Authors:  Justin A Mariani; David M Kaye
Journal:  J Cardiovasc Transl Res       Date:  2010-05-11       Impact factor: 4.132

3.  Fibrin microthreads support mesenchymal stem cell growth while maintaining differentiation potential.

Authors:  Megan K Proulx; Shawn P Carey; Lisa M Ditroia; Craig M Jones; Michael Fakharzadeh; Jacques P Guyette; Amanda L Clement; Robert G Orr; Marsha W Rolle; George D Pins; Glenn R Gaudette
Journal:  J Biomed Mater Res A       Date:  2011-02       Impact factor: 4.396

Review 4.  Percutaneous approaches for efficient cardiac gene delivery.

Authors:  Kiyotake Ishikawa; Jaume Aguero; Charbel Naim; Kenneth Fish; Roger J Hajjar
Journal:  J Cardiovasc Transl Res       Date:  2013-06-08       Impact factor: 4.132

Review 5.  Rescuing the failing heart by targeted gene transfer.

Authors:  Yoshiaki Kawase; Dennis Ladage; Roger J Hajjar
Journal:  J Am Coll Cardiol       Date:  2011-03-08       Impact factor: 24.094

6.  A naturally derived cardiac extracellular matrix enhances cardiac progenitor cell behavior in vitro.

Authors:  Kristin M French; Archana V Boopathy; Jessica A DeQuach; Loice Chingozha; Hang Lu; Karen L Christman; Michael E Davis
Journal:  Acta Biomater       Date:  2012-07-27       Impact factor: 8.947

7.  A novel approach for reducing ischemic mitral regurgitation by injection of a polymer to reverse remodel and reposition displaced papillary muscles.

Authors:  Judy Hung; Jorge Solis; J Luis Guerrero; Gavin J C Braithwaite; Orhun K Muratoglu; Miguel Chaput; Leticia Fernandez-Friera; Mark D Handschumacher; Van J Wedeen; Stuart Houser; Gus J Vlahakes; Robert A Levine
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

8.  New endovascular method for transvascular exit of arteries and veins: developed in simulator, in rat and in rabbit with full clinical integration.

Authors:  Johan Lundberg; Stefan Jonsson; Staffan Holmin
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

Review 9.  Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices.

Authors:  Jennifer M Singelyn; Karen L Christman
Journal:  J Cardiovasc Transl Res       Date:  2010-07-15       Impact factor: 4.132

Review 10.  Patient-specific computational modeling and magnetic nanoconstructs: tools for maximizing the efficacy of stem cell-based therapies.

Authors:  Paolo Decuzzi
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.